Global Therapeutic Landscape of Avian Influenza Drugs in Development 2021

DUBLIN, April 29, 2021 /PRNewswire/ -- The "Avian Influenza (Infectious Disease) - Drugs in Development, 2021" report has been added to ResearchAndMarkets.com's offering.

Avian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape.

The report provides comprehensive information on the therapeutics under development for Avian Influenza, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive Pharmacological Action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Avian Influenza and features dormant and discontinued projects.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

The report is built using data and information sourced from the publisher' proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

Scope of the report:

• The report provides a snapshot of the Global Therapeutic Landscape of Avian Influenza (Infectious Disease).
• The report reviews pipeline therapeutics for Avian Influenza (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The report covers pipeline products based on various stages of development ranging from discovery till pre-registration.
• The report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive MoA, R&D Brief, Licensing and Collaboration details & Other Developmental Activities.
• The report reviews key players involved in the development of Avian Influenza (Infectious Disease) therapeutics and enlists all their major and minor projects.
• The report assesses Avian Influenza (Infectious Disease) therapeutics based on Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type.
• The report summarizes all the dormant and discontinued pipeline projects.
• The report reviews latest news related to pipeline therapeutics for Avian Influenza (Infectious Disease).

Key Topics Covered:

• Indication - Overview
• Indication - Therapeutics Development
• Pipeline Overview
• Pipeline by Companies
• Pipeline by Universities/Institutes
• Products under Development by Companies
• Products under Development by Universities/Institutes
• Indication - Therapeutics Assessment
• Assessment by Target
• Assessment by Mechanism of Action
• Assessment by Route of Administration
• Assessment by Molecule Type
• Indication - Companies Involved in Therapeutics Development
• Indication - Drug Profiles
• R&D Progress
• Indication - Dormant Projects
• Indication - Discontinued Products
• Indication - Product Development Milestones
• Featured News & Press Releases

For more information about this report visit https://www.researchandmarkets.com/r/gj3l7a

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com   

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1904
Fax (outside U.S.): +353-1-481-1716

View original content:http://www.prnewswire.com/news-releases/global-therapeutic-landscape-of-avian-influenza-drugs-in-development-2021-301280243.html

SOURCE Research and Markets